| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | 詳細 | |
| Nesiritide | BNP-32 (human); JNS-004; hBNP; SC-70400 | Phase 2 Clinical | Johnson & Johnson | Myocardial Ischemia; Hyperemia; Heart Failure; Renal Insufficiency; Acutely decompensated congestive heart failure; Sleep Disorders, Circadian Rhythm; Hypertension; Dyspnea; Coronary Disease; Cardiomyopathies; Hyperinsulinism; Cardiovascular Diseases; Obesity; Diabetes Mellitus; Heart Failure, Systolic | 詳細 |
| PL-3994 | PL-3994 | Phase 2 Clinical | Palatin Technologies Inc | Heart Failure; Hypertension; Asthma | 詳細 |
| REGN-7544 | REGN-7544; REGN7544 | Phase 2 Clinical | Hypotension; Postural Orthostatic Tachycardia Syndrome | 詳細 | |
| XXB-750 | XXB-750 | Phase 2 Clinical | Novartis Pharma Ag | Heart Failure; Hypertension; Heart Failure, Systolic | 詳細 |
| GNP | Phase 2 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | 詳細 | |
| REGN-5381 | REGN-5381 | Phase 2 Clinical | Heart Failure | 詳細 | |
| Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Phase 1 Clinical | Suzhou RxD Biopharmaceutical Co Ltd | Heart Failure | 詳細 | |
| Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 1 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | 詳細 |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Heart Failure; Acutely decompensated congestive heart failure | 詳細 | |
| Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Hypotension; Heart Failure; Schizophrenia; Myocardial Infarction; Hypertension; Pulmonary Edema | 詳細 |
| Carperitide | SUN-4936; SUN-4936h; SUN-4936r; SUN-Y4936r; alpha-hANP; ANF (99-126); ANP (99-126); CDD (99-126) | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Heart Failure; Respiratory Distress Syndrome, Adult; Cardiomyopathies | 詳細 |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



